132 related articles for article (PubMed ID: 9052994)
1. Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor.
Thulasi R; Dias P; Houghton PJ; Houghton JA
Cell Growth Differ; 1996 Apr; 7(4):531-41. PubMed ID: 9052994
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
[TBL] [Abstract][Full Text] [Related]
3. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
4. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.
Shapiro DN; Jones BG; Shapiro LH; Dias P; Houghton PJ
J Clin Invest; 1994 Sep; 94(3):1235-42. PubMed ID: 8083365
[TBL] [Abstract][Full Text] [Related]
5. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
6. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor II (IGF-II), IGF binding protein-2 and myogenin during differentiation of myogenic satellite cells derived from the turkey.
Ernst CW; McFarland DC; White ME
Differentiation; 1996 Oct; 61(1):25-33. PubMed ID: 8921582
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin.
Li H; Choudhary SK; Milner DJ; Munir MI; Kuisk IR; Capetanaki Y
J Cell Biol; 1994 Mar; 124(5):827-41. PubMed ID: 8120103
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
11. MyoD, myogenin, and desmin-nls-lacZ transgene emphasize the distinct patterns of satellite cell activation in growth and regeneration.
Creuzet S; Lescaudron L; Li Z; Fontaine-Pérus J
Exp Cell Res; 1998 Sep; 243(2):241-53. PubMed ID: 9743584
[TBL] [Abstract][Full Text] [Related]
12. Aphidicolin induces myogenic differentiation in the human rhabdomyosarcoma cell line KFR.
Cinatl J; Cinatl J; Driever PH; Rabenau H; Novak M; Stefanik M; Kornhuber B; Doerr HW
Cell Biol Int; 1994 Apr; 18(4):271-8. PubMed ID: 8044142
[TBL] [Abstract][Full Text] [Related]
13. Decorin activates Akt downstream of IGF-IR and promotes myoblast differentiation.
Suzuki K; Kishioka Y; Wakamatsu J; Nishimura T
Anim Sci J; 2013 Sep; 84(9):669-74. PubMed ID: 23607268
[TBL] [Abstract][Full Text] [Related]
14. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
Minniti CP; Luan D; O'Grady C; Rosenfeld RG; Oh Y; Helman LJ
Cell Growth Differ; 1995 Mar; 6(3):263-9. PubMed ID: 7794794
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
17. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
[TBL] [Abstract][Full Text] [Related]
18. Testosterone enables growth and hypertrophy in fusion impaired myoblasts that display myotube atrophy: deciphering the role of androgen and IGF-I receptors.
Hughes DC; Stewart CE; Sculthorpe N; Dugdale HF; Yousefian F; Lewis MP; Sharples AP
Biogerontology; 2016 Jun; 17(3):619-39. PubMed ID: 26538344
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
20. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin.
Szalay K; Rázga Z; Duda E
Eur J Cell Biol; 1997 Dec; 74(4):391-8. PubMed ID: 9438136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
